Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Kineta Chronic Pain identifies NACHR alpha-9/alpha-10 antagonists

July 28, 2020

New Nav1.7 sodium channel blockers described by Harvard College, Children's Medical Center

July 28, 2020

Studying labor identifies new pain mechanism

July 28, 2020

Alector begins phase III trial of AL-001 in frontotemporal dementia

July 27, 2020

FDA maintains clinical hold on IGNITE DMD study of SGT-001

July 27, 2020

Jiangsu Hengrui Medicine, Shanghai Hengrui Pharmaceutical patent Nav1.8 channel blockers

July 27, 2020

NP strategy selectively targets brain microvasculature

July 27, 2020

Potent dual orexin OX1/2 receptor antagonist with improved PK profile for insomnia treatment

July 23, 2020

TTX-3360 selected as Triplet's first clinical candidate for repeat expansion disorders

July 23, 2020

Huntington's disease found to alter neurodevelopment

July 23, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 21, 2026.
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
WHO declares Ebola outbreak a public health emergency of international concern
BioWorld
The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...
Nxera Pharma prepares and tests new GPR17 antagonists
BioWorld Science
Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...